Caption Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Caption Management’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-90,000	Closed	-$3.49M	–	1849
2025 Q3	$3.49M	Sell	90,000 -1,052,500	-92%	-$34.2M	0.03%	620
2025 Q2	$31.6M	Buy	1,142,500 +1,112,500	+3,708%	+$28.3M	0.35%	48
2025 Q1	$666K	Buy	+30,000	New	+$617K	0.01%	1024
2024 Q4	–	Sell	-30,000	Closed	-$750K	–	1655
2024 Q3	$750K	Buy	+30,000	New	+$731K	0.01%	848
2024 Q1	–	Sell	-195,100	Closed	-$3.42M	–	1453
2023 Q4	$3.42M	Buy	195,100 +105,100	+117%	+$1.73M	0.05%	467
2023 Q3	$1.56M	Buy	90,000 +30,000	+50%	+$505K	0.02%	642
2023 Q2	$845K	Sell	60,000 -5,000	-8%	-$66.9K	0.02%	702
2023 Q1	$699K	Buy	65,000 +30,000	+86%	+$395K	0.01%	713
2022 Q4	$524K	Buy	35,000 +5,000	+17%	+$72.8K	0.01%	913
2022 Q3	$386K	Sell	30,000 -30,000	-50%	-$342K	0.01%	1127
2022 Q2	$581K	Sell	60,000 -45,000	-43%	-$420K	0.01%	1040
2022 Q1	$1.04M	Buy	105,000 +30,000	+40%	+$318K	0.01%	959
2021 Q4	$883K	Buy	75,000 +45,000	+150%	+$553K	0.01%	1089
2021 Q3	$342K	Hold	30,000	–	–	﹤0.01%	1270
2021 Q2	$418K	Sell	30,000 -30,000	-50%	-$456K	0.01%	1084
2021 Q1	$1.11M	Buy	60,000 +30,000	+100%	+$614K	0.02%	663
2020 Q4	$530K	Sell	30,000 -500	-2%	-$8.78K	0.01%	731
2020 Q3	$467K	Buy	+30,500	New	+$573K	0.01%	784

Other funds holding KNSA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Caption Management's KNSA Position: Q3 2024 in Review

Caption Management sold out of Kiniksa Pharmaceuticals (KNSA) in Q3 2024, closing a stake of 4,065 shares — an estimated $99K sold.

Caption Management first reported a position in KNSA in Q3 2020 and held it in 9 quarters. The position peaked at $651K in Q1 2022. 176 funds tracked by Wall St. Rank hold KNSA as of Q3 2024.

Caption Management reported no remaining Kiniksa Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Caption Management sold 4,065 Kiniksa Pharmaceuticals shares in Q3 2024, an estimated $99K.
Caption Management first reported a position in Kiniksa Pharmaceuticals in Q3 2020 and held it in 9 quarters.
Caption Management's Kiniksa Pharmaceuticals position peaked at $651K in Q1 2022.
176 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.